External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

ESPN 2024

-
Coming soon
11:40 AM
Duration 1hr Valencia, Spain
The ongoing Phase 3 COMMUTE-a and -p trials of crovalimab in atypical haemolytic uraemic syndrome and patient preference for crovalimab vs eculizumab in the Phase 3 COMMODORE 1 and 2 trials
Gentile B, Stefani J, Buri M, Leon P

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar